Hereditary angioedema: epidemiology, management, and role of icatibant

References

• NzeakoUCFrigasETremaineWJHereditary angioedema: a broad review for cliniciansArch Intern Med2001161202417242911700154
   PubMedGoogle Scholar
• BorkKBarnstedtSEKochPHereditary angioedema with normal C1-inhibitor activity in womenLancet200035621321710963200
   PubMed Web of Science ®Google Scholar
• DavisAE3rdThe pathophysiology of hereditary angioedemaClin Immunol200511413915596403
   PubMed Web of Science ®Google Scholar
• CicardiMAgostoniAHereditary angioedemaN Engl J Med1996334166616678628365
   PubMed Web of Science ®Google Scholar
• QuinckeHConcerning the acute localized edema of the skinMonatsh Prakt Derm18821129131 German
   Google Scholar
• OslerWHereditary angioneurotic edemaAm J Med Sci1888954362367
   Google Scholar
• DonaldsonVHEvansRRA biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C’ 1-esteraseAm J Med196335374414046003
   PubMed Web of Science ®Google Scholar
• DreskinSUrticaria and angioedemaGoldmanLSchaferAICecil Medicine24th edPhiladelphia, PASaunders Elsevier2011 chap 260
   Google Scholar
• TalaveraALarraonaJLRamosJLHereditary angioedema: an infrequent cause of abdominal pain with ascitesAm J Gastroenterol1995904714747872288
   PubMed Web of Science ®Google Scholar
• AgostoniAAygören-PürsünEBinkleyKEHereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJ Allergy Clin Immunol2004114Suppl 3S51S13115356535
   PubMed Web of Science ®Google Scholar
• FrankMMGelfandJAAtkinsonJPHereditary angioedema: the clinical syndrome and its managementAnn Intern Med1976845805931275365
   PubMed Web of Science ®Google Scholar
• PappalardoECicardiMDuponchelCFrequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedemaJ Allergy Clin Immunol200010661147115411112899
   PubMed Web of Science ®Google Scholar
• DavisAE3rdC1 inhibitor and hereditary angioneurotic edemaAnnu Rev Immunol198865956283289579
   PubMed Web of Science ®Google Scholar
• BorkKHereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutationsImmunol Allergy Clin North Am20062670972417085286
   PubMed Web of Science ®Google Scholar
• BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs and courseAm J Med200611926727416490473
   PubMed Web of Science ®Google Scholar
• SofaSCasaliABolondiLSonographic findings in abdominal hereditary angioedemaJ Clin Ultrasound19992753754010525217
   PubMed Web of Science ®Google Scholar
• BorkKSiedleckiKBoschSSchopfREKreuzWAsphyxiation by laryngeal edema in patients with hereditary angioedemaMayo Clin Proc20007534935410761488
   PubMed Web of Science ®Google Scholar
• BorumMLHowardDEHereditary angioedema: complex symptoms can make diagnosis difficultPostgrad Med1998103251255256
   Google Scholar
• GompelsMMLockRJAbinunMC1 inhibitor deficiency: consensus documentClin Exp Immunol2005139337939415730382
   PubMed Web of Science ®Google Scholar
• Wagenaar-BosIGDrouetCAygören-PursunEFunctional C1-Inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendationsJ Immunol Methods2008338142018655790
   PubMed Web of Science ®Google Scholar
• BowenTCicardiMFarkasHCanadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary AngioedemaJ Allergy Clin Immunol2004114362963715356569
   PubMed Web of Science ®Google Scholar
• BowenTCicardiMFarkasH2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma Clin Immunol2010612420667127
   PubMedGoogle Scholar
• CicardiMBorkKCaballeroTHAWK (Hereditary Angioedema International Working Group)Evidence-based recommendations for the therapeutic management of angioedema owing to the hereditary C1 inhibitor deficiency: consensus report of an International Working GroupAllergy201267214715722126399
   PubMed Web of Science ®Google Scholar
• ZurawBLBussePJWhiteMNanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaN Engl J Med2010363651352220818886
   PubMed Web of Science ®Google Scholar
• ZurawBCicardiMLevyRJRecombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedemaJ Allergy Clin Immunol20101264821827e1420920772
   PubMed Web of Science ®Google Scholar
• CicardiMLevyRJMcNeilDLEcallantide for the treatment of acute attacks in hereditary angioedemaN Engl J Med201036352353120818887
   PubMed Web of Science ®Google Scholar
• LevyRJLumryWRMcNeilDLEDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaAnn Allergy Asthma Immunol2010104652352920568386
   PubMed Web of Science ®Google Scholar
• CraigTJLevyRJWassermanRLEfficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksJ Allergy Clin Immunol2009124480180819767078
   PubMed Web of Science ®Google Scholar
• AgostoniACicardiMHereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patientsMedicine (Baltimore)19927142062151518394
   PubMed Web of Science ®Google Scholar
• LonghurstHJFarkasHCraigTHAE international home therapy consensus documentAllergy Asthma Clin Immunol2010612220667125
   PubMedGoogle Scholar
• CugnoMZanichelliAFoieniFCacciaSCicardiMC1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressTrends Mol Med200915697819162547
   PubMed Web of Science ®Google Scholar
• CugnoMNussbergerJCicardiMAgostoniABradykinin and the pathophysiology of angioedemaInt Immunopharmacol20033331131712639808
   PubMed Web of Science ®Google Scholar
• NussbergerJCugnoMCicardiMBradykinin-mediated angioedemaN Engl J Med2002347862162212192030
   PubMed Web of Science ®Google Scholar
• HanEDMacFarlaneRCMulliganANScafidiJDavisAE3rdIncreased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptorJ Clin Invest200210981057106311956243
   PubMed Web of Science ®Google Scholar
• BorkKFrankJGrundtBSchlattmannPNussbergerJKreuzWTreatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)J Allergy Clin Immunol200711961497150317418383
   PubMed Web of Science ®Google Scholar
• HockFJWirthKAlbusUHoe 140 a new potent and long acting bradykinin-antagonist: in vitro studiesBr J Pharmacol199110237697731364851
   PubMed Web of Science ®Google Scholar
• WirthKHockFJAlbusUHoe 140 a new potent and long acting bradykinin-antagonist: in vivo studiesBr J Pharmacol199110237747771364852
   PubMed Web of Science ®Google Scholar
• FélétouMMartinCAMolimardMIn vitro effects of HOE 140 in human bronchial and vascular tissueEur J Pharmacol19952741–357647768281
   PubMed Web of Science ®Google Scholar
• DeeksEDIcatibantDrugs2010701738120030426
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency CHMP assessment report for Firazyr®11172008 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/000899/WC500022970.pdfAccessed April 5, 2013
   Google Scholar
• CicardiMBanerjiABrachoFIcatibant, a new Bradykinin-receptor antagonist, in hereditary angioedemaN Eng J Med2010363532541
   PubMed Web of Science ®Google Scholar
• LumryWRLiHHLevyRJRandomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialAnn Allergy Asthma Immunol2011107652953722123383
   PubMed Web of Science ®Google Scholar
• Advisory Committee Meeting Briefing Package. Firazyr® (Icatibant)Cambridge, MAShire Human Genetic Therapies, Inc2011 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugs/AdvisoryCommittee/UCM260022.pdfAccessed April 4, 2013
   Google Scholar
• SharmaJNCardiovascular activities of the bradykinin systemScientificWorldJournal2008838439318454246
   PubMed Web of Science ®Google Scholar
• SharmaJNHypertension and the bradykinin systemCurr Hypertens Rep200911317818119442326
   PubMed Web of Science ®Google Scholar
• Shire Human Genetic Therapies, IncA Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema Clinical Trials gov. Last verified : February 2013. Available from http://clinicaltrials.gov/show/NCT01386658. NLM identifier: NCT01386658Accessed April 9, 2013
   Google Scholar
• ToscaniMRiedlMMeeting the challenges and burdens associated with hereditary angioedemaManag Care2011209445121991862
   PubMedGoogle Scholar
• LumryWRCastaldoAJVernonMKBlausteinMBWilsonDAHornPTThe humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depressionAllergy Asthma Proc201031540741420929608
   PubMed Web of Science ®Google Scholar
• WilsonDABorkKSheaEPRentzAMBlausteinMBPullmanWEEconomic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol2010104431432020408341
   PubMed Web of Science ®Google Scholar
• AlejandroMalbránWernerAbererWilliamLumryPatient Satisfaction with Icatibant During Open-Label Treatment of Hereditary Angioedema Attacks in the FAST-1 and FAST-2 Phase III TrialsPoster presented at EAACI 2011Istanbul, Turkey Available from: http://www.postersessiononline.com/173580348_eu/congresos/30eaaci/aula/poster_42561.pdfAccessed April 9, 2013
   Google Scholar
• BowenTHereditary angioedema: beyond international consensus – circa December 2010. The Canadian Society of Allergy and Clinical Immunology Dr David McCourtie LectureAllergy Asthma Clin Immunol201171121310025
   PubMed Web of Science ®Google Scholar
• FloccardBHautinEBouilletLCoppereBAllaouchicheBAn evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and IICore Evid2012710511423055948
   PubMedGoogle Scholar
• Aygören-PürsünEMartinez-SaguerIRusickeEKlingebielTKreuzWOn demand treatment and home therapy of hereditary angioedema in Germany – the Frankfurt experienceAllergy Asthma Clin Immunol2010612120667124
   PubMedGoogle Scholar
• BlankartCRStargardtTSchreyoggJAvailability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukemiaPharmacoeconomics2011291638221073206
   PubMed Web of Science ®Google Scholar
• SimoensSPricing and reimbursement of orphan drugs: the need for more transparencyOrphanet J Rare Dis201164221682893
   PubMed Web of Science ®Google Scholar
• MaurerMAbererWBouilletLHereditary angioedema attacks resolve faster and are shorter after early icatibant treatmentPLoS One201382e5377323390491
   PubMed Web of Science ®Google Scholar
• ZurawBLClinical practice. Hereditary angioedemaN Engl J Med2008359101027103618768946
   PubMed Web of Science ®Google Scholar
• LonghurstHCicardiMHereditary angioedemaLancet2012379981447448122305226
   PubMed Web of Science ®Google Scholar
• BouilletLIcatibant in hereditary angioedema: news and challengesExpert Rev Clin Immunol20117326727221595592
   PubMed Web of Science ®Google Scholar
• BrightPDempsterJLonghurstHSuccessful treatment of acquired C1 inhibitor deficiency with icatibantClin Exp Dermatol201035555355420337653
   PubMed Web of Science ®Google Scholar
• BouilletLHereditary angioedema in womenAllergy Asthma Clin Immunol2010611720667120
   PubMedGoogle Scholar
• BouilletLBoccon-GibodIPonardDBradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacksAnn Allergy Asthma Immunol2009103544819927548
   PubMed Web of Science ®Google Scholar
• WellerKMagerlMMaurerMSuccessful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibantJ Eur Acad Dermatol Venereol201125111912020477917
   PubMed Web of Science ®Google Scholar
• GallitelliMAlzettaMIcatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitorsAm J Emerg Med20123081664e1e222100478
   PubMed Web of Science ®Google Scholar
• GuichonCFloccardBCoppéréBOne hypovolaemic shock… two kinin pathway abnormalitiesIntensive Care Med20113771227122821484080
   PubMed Web of Science ®Google Scholar
• BasMGreveJStelterKTherapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case seriesAnn Emerg Med201056327828220447725
   PubMed Web of Science ®Google Scholar
• Vanderbilt UniversityEffect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated AngioedemaClinical Trials gov [website on the Internet]Bethesda, MDUS National Library of Medicine122012 Available from: http://clinicaltrials.gov/ct2/show/NCT01574248. NLM identifier: NCT01574248Accessed April 4, 2013
   Google Scholar